Özet:

In 2011, a research panel funded by the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society and European Respiratory Society proposed a variety of significant improvements to all lung tumours prior to lung adenocarcinoma. Furthermore, the recommendations were adopted in this study panel with only minor changes and were identified as the 2015 World Health Organization (WHO) classification of lung tumours. Most of the studies conducted to establish this classification were realised by ‘the IASLC Pathology Committee’. Leading experts in these fields have given their approval to certain subheadings for the organization and have accepted the WHO book. The most recent classification of lung, pleura, thymus and heart tumours was published by the WHO in 2015. Over the last 15 years, the classification of lung cancer has undergone major changes since the WHO classification in 2004 due to the effects of genetic research on lung cancer and important advances in target therapies. In this review article, these changes will be assessed from a pathologist’s perspective.

Anahtar Kelimeler: